C ardiovascular disease is the leading cause of mortality in patients with chronic kidney disease. 1, 2 Aortic stiffness, which results in increased pulse pressure (PP), cardiac overload, and left ventricular hypertrophy, is an established predictor for cardiovascular morbidity and mortality in chronic kidney disease. [3][4][5] Physiologically, the aorta is much more elastic than peripheral muscular arteries providing a physiological stiffness gradient. This physiological gradient of stiffness generates reflecting sites, which dampens the transmission of forward travelling pressure into the microcirculation. In normal aging, aortic stiffness increases to a greater extent than peripheral muscular arteries, resulting in equalization or even reversal of stiffness gradient (aortic stiffness>muscular artery stiffness), referred to as stiffness mismatch. 6-9 Attenuation or reversal of physiological stiffness gradient has been proposed to cause vascular damage through enhanced transmission of forward travelling wave energy into the microcirculation.
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Methods
Study Design and Population
This was a single-center observational longitudinal study examining the effect of central and peripheral arterial stiffness on overall mortality. All patients were adults on chronic (>3 months) peritoneal dialysis or hemodialysis with stable dry weight. Sixteen subjects were excluded for missing central or peripheral vascular stiffness, leaving 310 subjects for the study analysis ( Figure 1 ).
Patients' contribution to follow-up ended at the time of death, renal transplantation, renal recovery, or at the past follow-up (July 2012; detailed Methods are available in the online-only Data Supplement).
Objectives
The primary objective of the study was to assess the effect of the aortic-brachial stiffness mismatch on mortality. The aorticbrachial stiffness mismatch was defined by ratio of carotid-femoral to carotid-brachial PWV (PWV ratio). The secondary objectives were (1) to identify the demographic, clinical, biological, pharmacological, and hemodynamic determinants of PWV ratio, and (2) to study the predictive value of the PWV ratio with regard to mortality as compared with other hemodynamic indicators of arterial stiffness.
Hemodynamic Parameters
Brachial artery blood pressure (BP) was recorded using an automatic sphygmomanometer BPM-100 (BP-Tru, Coquitlam, Canada). 12 We determined carotid-femoral pulse wave velocity (cf-PWV) and carotid-radial pulse wave velocity (cr-PWV) using Complior SP (Artech Medical, Pantin, France) as described previously. 11, 13 PWV ratio was calculated from the average cf-PWV and cr-PWV (PWV ratio=cf-PWV/cr-PWV). For the purpose of comparison to the reference values published, standard cf-PWV was obtained as previously reported.
14 Central pulse wave profile was derived from radial artery tonometry (SphygmoCor system; AtCor Medical Pty. Ltd, Sydney, Australia) to assess central systolic blood pressure, diastolic blood pressure, mean blood pressure, PP, heart-rate-adjusted central augmentation index (AIx@75), augmented pressure, time of reflection wave (Tr), first and second peak of pressure (P1, P2) with their respective time (T1, T2), and subendocardial viability ratio as previously described and validated. 15 Forward pressure wave (Pf), backward pressure wave (Pb), reflection magnitude, and reflection index were obtained by the use of triangulation method for aortic flow 16, 17 (Detailed Methods are available in the online-only Data Supplement).
Biological Parameters
Lipid profile, mineral metabolism, hemoglobin, and C-reactive protein were measured by clinical biochemistry laboratory on predialysis samples. To compare dialysis adequacy with regard to the modality of treatment, we used standardized Kt/V 18 (Detailed Methods are available in the online-only Data Supplement).
Statistical Analysis
The detailed statistical analysis is available in online-only Data Supplement. 
Results
Baseline Characteristics Table 1 shows demographic, clinical, pharmacological, and biological characteristics of patients at baseline. Hemodynamic parameters are shown in Table 2 for the whole cohort and according to tertiles of PWV ratio. Despite similar heart rate and mean blood pressure, there were higher systolic blood pressure, PP, P f , and AIx@75, and lower diastolic blood pressure, subendocardial viability ratio, and PP amplification with increasing tertiles of the PWV ratio. Table 3 shows the clinical, biological, and pharmacological correlates of PWV Results are mean±SD or n (%). As appropriate, 1-way ANOVA, Kruskal-Wallis, Student t, and Mann-Whitney U tests were used with Bonferonni correction for multiple comparisons. AIx@75 indicates augmentation index adjusted for heart rate; AP, augmented pressure; cf-PWV, carotid-femoral pulse wave velocity; cr-PWV, carotid-radial pulse wave velocity; DBP, diastolic blood pressure; DPTI, diastolic pressure time index; MBP, mean blood pressure; P1, first peak of pressure; P2, second peak of pressure; Pb, backward pressure wave; Pf, forward pressure wave; PP, pulse pressure; PWV, pulse wave velocity; RI, reflection index; RM, reflection magnitude; SBP, systolic blood pressure; SEVR, subendocardial viability ratio; SPTI, systolic pressure time index; T1, time at first peak of pressure; T2, time at second peak of pressure; and Tr, time of reflection wave.
* 
Effect of the PWV Ratio on Survival
Overall, 146 (47%) deaths occurred after a median follow-up of 29 months (12 to 51). The Kaplan-Meier analysis ( Figure 2 ) shows an increased rate of mortality with increasing tertiles of PWV ratio (P=0.001). Using PWV ratio as a continuous variable in a Cox regression analysis, we show in Table 4 the effect of PWV ratio on the risk of mortality in both nonadjusted and various adjusted models, which take into account potential confounding factors, such as age, dialysis vintage, and other comorbidities (Models 1 to 3). Standardized Kt/V, dialysis modality, and mean blood pressure did not affect significantly the risk of mortality associated to PWV ratio (Table  S1 in the online-only Data Supplement). Although the use of nitrate was found to be a significant determinant of PWV ratio in the univariate analysis, we started by incorporating the use of nitrate into the model 4, which shows that PWV ratio was still significantly associated with increased risk of mortality. Subsequently, as part of the sensitivity analysis, we performed survival analysis by excluding patients who were taking nitrate (n=50). Among patients not taking nitrate (n=260), 113 (43.5%) deaths occurred. Results that are presented in Table 4 show similar findings in both nonadjusted and adjusted models.
In an exploratory analysis, we used a forward conditional multivariate Cox regression analysis, which included demographic, clinical, pharmacological, and biochemical parameters that could potentially have been associated with mortality. In this analysis, only PWV ratio, age, dialysis vintage, and C-reactive protein were associated with increased risk of mortality (Table S2) . Figure 3 shows receiver operating characteristic curves of the 4 most significant hemodynamic parameters associated with mortality. Among central and peripheral hemodynamic parameters, PWV ratio showed the highest AUC with regard to mortality (Table S3) . Indeed, AUC of PWV ratio was statistically higher than that of cf-PWV (P=0.001) and AIx@75 (P=0.04). Figure 4 shows the risk associated with changes in 1 SD of each of the hemodynamic parameters, showing that higher PWV ratio, AIx@75, cf-PWV, reflection magnitude, reflection index, and lower cr-PWV, PP amplification, and subendocardial viability ratio were significantly associated with increased risk of mortality in univariate Cox regression analyses. Contrary to PWV ratio, the hazard ratios associated with cf-PWV, cr-PWV, AIx, PP amplification, subendocardial viability ratio, reflection magnitude and reflection index, were no longer statistically significant after adjustment for age.
Comparison of Indicators of Arterial Stiffness in Predicting Outcome
Discussion
This study shows for the first time that reversal of aortic-brachial arterial stiffness gradient, assessed by PWV ratio, is a Univariate linear regressions show only the demographic, biochemical, and pharmacological variables that were significantly associated with PWV ratio. Only significant variables were included in a stepwise multivariate linear regression. ASA indicates acetylsalicylic acid; CRP, C-reactive protein; CVD, cardiovascular disease; PTH, parathyroid hormone; PWV, pulse wave velocity; and Std Coefficient, standardized regression coefficient.
* PTH, CRP, and dialysis vintage were log 10 transformed and age was transformed to age 3 .
strong independent predictor of mortality in patients on dialysis, even after multiple adjustments for confounding risk factors. We also demonstrated that PWV ratio is a more powerful prognostic indicator of mortality than aortic stiffness, central PP, PP amplification, or AIx. Aorta is a major capacitive vessel, which through its elasticity dampens the pulsatile nature of the intermittent cardiac output and provides a continuous blood flow during diastole with minimal cardiac work output. During normal aging and under pathological conditions (hypertension, diabetes mellitus, and chronic kidney disease), enhanced aortic stiffness leads to increased PWV, earlier wave reflection and increased cardiac workload and left ventricular hypertrophy. 5, [19] [20] [21] However, peripheral muscular conduit arteries, such as brachial artery, are much stiffer than aorta. It has been proposed that the physiological gradient of stiffness contributes to the attenuation of the transmission of forward travelling wave into the microcirculation, therefore, providing protection against PP-induced changes in microvasculature. Stiffness of brachial artery is less affected by age as compared with aortic stiffness, and may even start to decrease after the fifth decade of life. 6, 7, 22, 23 In a longitudinal study with repeated measures of PWV in hemodialysis patients, we observed that the reduction of brachial stiffness was inversely associated to baseline degree of aortic stiffness. 11 This finding along with others, 9, 24 have led to propose that regression of brachial stiffness could be an adaptation to an increased central aortic stiffness. Indeed, the reduction in the stiffness of peripheral muscular arteries in the presence of high aortic stiffness will attenuate wave reflection, contributing to the shifting of the reflecting sites distally, potentially reducing the negative effect of wave reflection on central blood pressure and cardiac workload (ie, adaptation) and explaining the discordance between augmentation index and aortic stiffness. 8, 25 Although this may be an adaptation from a cardiac point of view, it may have a negative effect on peripheral organs that are sensitive to PP. Indeed, the reduced reflection of forward travelling pressure wave results in the transmission of greater forward pressure wave into the microcirculation. This could lead to microvascular endothelial dysfunction, remodeling, and increase myogenic tone, therefore, contributing to the alterations in organ perfusion and organ dysfunction. 9, 10, 23, [26] [27] [28] [29] In dialysis patients, while Pannier et al 4 observed that aortic PWV was a strong predictor of cardiovascular mortality, they failed to show that PWV of peripheral muscular arteries (femoral and brachial) had any prognostic value. In contrast, our study shows that a higher aortic stiffness and a lower brachial stiffness were associated with increased mortality. The discrepancy between our findings and that of Pannier et al 4 regarding brachial stiffness could be related to the characteristics of our subjects who were on average aged 16 years older, with a higher prevalence of cardiovascular disease (52% versus 29%) and diabetes mellitus (43% versus 10%). Nevertheless, in our study, after adjustment for age, the effect of both aortic stiffness and brachial stiffness on mortality was no longer statistically significant. Among the tested hemodynamic parameters, only the PWV ratio remained statistically significant in multivariate adjusted models.
The use of acetylsalicylic acid, statins, β-blockers, and nitrate were associated with higher PWV ratio in univariate analyses. However, after adjustment for age, cardiovascular disease, and diabetes mellitus, they were no longer statistically significant. Therefore, they could be considered confounding elements by indication bias. Nevertheless, because of the potent effects of nitrate on muscular arteries, it is also biologically conceivable that the PWV ratio might have been higher with nitrate as the result of a reduction of brachial artery stiffness (muscular artery). To address these potential confounding effects of nitrate, we first adjusted for the use of nitrate by including it as a covariate into the survival analysis. Because these adjustments may have inherent limitations, we performed similar survival analysis by excluding all patients with nitrate. The results show that PWV ratio remains a robust determinant using either of the 2 approaches, suggesting our findings were not the result of contamination by the use of nitrate.
The study has several strengths because it provides a detailed hemodynamic phenotyping of a relatively large number of dialysis patients with sufficient follow-up to assess clinically relevant outcomes without any loss to follow-up. Overall, our study population is representative of the actual North American dialysis population in terms of age, diabetes mellitus, hypertension, and cardiovascular disease. In addition, in light of the growing use of brachial-ankle PWV, which assumes the homogeneity of the arterial tree, the results of this study are based on the exploitation of the heterogeneity of the arterial tree. However, the study has some limitations that need to be mentioned. Biologically, it is expected that PWV ratio would affect cardiovascular outcomes, therefore, it would have been interesting to assess the effect of PWV ratio on cardiovascular events and cardiovascular mortality. But because of geographically dispersion of patients, it was not possible to reliably assess all cardiovascular events and the cause of mortality. Second, defining cardiovascular events and mortality in dialysis population remains a challenging task. As an example, heart failure can be the result of fluid overload, a patient can choose to stop dialysis because of a stroke or an expected amputation, and death can occur as a result of hyperkalemiainduced arrhythmia. Finally, the study was not designed to study the longitudinal structural changes in the brachial artery, which would have helped to examine whether reduced brachial PWV is the result of a reduction in the incremental elastic modulus or because of changes in the wall-to-lumen ratio.
Perspectives
Over the past decades, tremendous amount of work has been done to underline the importance of the physiological role that aorta plays in the regulation of blood flow and the importance of ventricular-aortic coupling. Although aortic stiffness has been associated with clinical outcomes, its role is now well-accepted in the assessment of cardiovascular risk. However, the lack of the association of brachial and femoral stiffness with clinical outcomes may have overshadowed the importance of the integrated role that peripheral muscular arteries play in the cardiovascular system. In this context, our results underline the importance of the interaction between aorta and muscular peripheral arteries showing that aortic-brachial stiffness mismatch (PWV ratio) seems to be a stronger predictor of all-cause mortality than aortic or brachial stiffness. However, further studies are required to examine the effect of PWV ratio on cardiovascular outcomes in dialysis population and to confirm these findings in lowerrisk cohorts. In addition, the effect of antihypertensive drugs on aortic-brachial stiffness mismatch needs further studies. • The mismatch between aortic and brachial stiffness as determined by the pulse wave velocity ratio is a better prognostic tool than either aortic or brachial stiffness alone.
What Is Relevant?
• There is heterogeneity in the biomechanical properties of large vessels.
This heterogeneity can be exploited to study the interaction of aorta (central elastic vessel) with peripheral muscular conduit arteries.
Summary
The reversal of aortic-brachial arterial stiffness gradient, assessed by PWV ratio, is a strong independent predictor of mortality in patients on dialysis, even after multiple adjustments for confounding risk factors. We also demonstrated that aortic-brachial stiffness mismatch is a more powerful prognostic indicator of mortality than aortic stiffness, central pulse pressure, pulse pressure amplification, or augmentation index. 
SUPPLEMENTAL METHODS
Study design and population
This was a single center observational longitudinal study examining the impact of central and peripheral arterial stiffness on overall mortality, which was conducted at CHU de Québec -L'Hôtel-Dieu de Québec Hospital. Between August 2006 and July 2012, 326 patients underwent at least one extensive evaluation for medical history, laboratory data, pharmacological treatment and hemodynamic parameters of arterial stiffness. This cohort of patients was composed of adult patients on chronic (>3 months) peritoneal dialysis (PD) or hemodialysis (HD) with stable dry weight. All patients were treated according to the KDOQI Clinical Practice Guidelines of CKD care and dialysis adequacy. 1 The exclusion criteria of this cohort were any clinical conditions that would hamper hemodynamic measurements (absence of femoral pulse, systolic blood pressure of <90 mmHg) or acute episode of illness (infection, acute heart failure, active bleeding) as previously reported. 2 We further excluded patient with missing data for central or peripheral vascular stiffness (n=16), leaving 310 subjects for the study analysis ( Figure  1 ). Patients' contribution to follow-up ended at the time of death, renal transplantation, renal recovery or at the last follow-up (July 2012). Death was ascertained by consultation of the Attestation of Death form. History of cardiovascular disease was defined by a history of stroke, myocardial infarction, coronary revascularization, lower extremity amputation or revascularization. The study was approved by the institution review board and was conducted in accordance to the Declaration of Helsinki. All patients provided informed consent.
Hemodynamic parameters
Hemodynamic measurements were performed after 15 minutes of rest in a supine position prior to the mid-week dialysis session in hemodialysis patients. In case of an arterio-venous fistula, measurements were performed on the contralateral arm. Brachial artery blood pressure (BP) was recorded using an automatic sphygmomanometer BPM-100 (BP-Tru, Coquitlam, Canada). BP was recorded 6 times, with a 2-minutes interval between each measurement, and the average of the last 5 measurements was used to determine the brachial systolic blood pressure (SBP) and diastolic blood pressure (DBP). 3 We determined carotid-femoral pulse wave velocity (cf-PWV) and carotid-radial pulse wave velocity (cr-PWV) using Complior® SP (Artech Medical, Pantin -France) as described previously. 2, 4 In our laboratory, the intra-session and intersession coefficient of variation of PWV are respectively 2.9% and 8.9%. PWV ratio was calculated from the average cf-PWV and cr-PWV (PWV ratio = cf-PWV/cr-PWV). For the purpose of comparison to the reference values published, standard cf-PWV was obtained taking into account differences in the transit time using the maximal upstroke algorithm, and the overestimation of true distance by multiplying direct distance by 0.8. 5 An abnormal cf-PWV is defined as a standard cf-PWV that is superior to the decade specific 90th percentile of normal subjects. 5 To assess central pulse wave profile, radial pulse wave profile was recorded by aplanation tonometry after recalibration with brachial SBP and DBP (SphygmoCor system, AtCor Medical Pty. Ltd., Sydney, Australia). Three consecutive recordings were performed and central pulse wave profile was constructed using the generalized transfer function, from which central SBP, DBP, mean BP (MBP), pulse pressure (PP), heart-rate-adjusted central augmentation index(AIx@75), augmented pressure (AP), time of reflection wave (Tr), first and second peak of pressure (P1, P2) with their respective time (T1, T2) and subendocardial viability ratio (SEVR) were derived as previously described and validated (supplementary Figure 1) . 6 Forward pressure wave (P f ), backward pressure wave (Pb), reflection magnitude (RM) and reflection index (RI) were obtained by the use of triangulation method for aortic flow. 7, 8 
Biochemical Analysis
Lipid profile, mineral metabolism, hemoglobin and C-reactive protein (CRP) were measured by clinical biochemistry laboratory on pre-dialysis samples. In order to assure reliability of the exposure, the mean value of calcium, phosphate and hemoglobin for the preceding and the following 3 months, and the median value of PTH and CRP of the preceding and following year. The median number of PTH and CRP measurements per patient were 4 and 2 respectively. PTH was measured with the PTH stat assay from Roche diagnostics using two antibodies reactive with epitopes in the amino acid regions 26-32 and 37-42. In order to compare dialysis adequacy with regard to the modality of treatment, we used standardized Kt/V (std Kt/V).
1
Data Analysis
Data is expressed as means ± SD, n (%) or median [25 th -75 th percentiles].As appropriate, one-way ANOVA, Kruskal-Wallis, student-t and Mann-Whitney U tests were used with Bonferonni correction for multiple comparisons, in order to compare baseline hemodynamic parameters of tertiles of PWV ratio. Data that did not follow normal distribution were log 10 transformed (dialysis vintage, PTH, CRP) and age underwent cubic transformation for linear and Cox regressions. In order to study the determinants of PWV ratio, we included in a stepwise multivariate linear regression the demographic, clinical, biological and pharmacological parameters that were associated with PWV ratio in univariate linear regressions. Graphical residual analyses were performed to ensure the assumptions of normality, linearity and homoscedasticity. The independence of observations was confirmed using the Durbin-Watson statistic. Outliers were examined by Cook's distance and leverage analyses were used to identify influential points. Analysis, repeated after elimination of these points, was consistent with the initial results, confirming that the model was appropriate. Comparisons of survival between tertiles of PWV ratio were done using Kaplan-Meier analysis. After confirming that the assumption of proportionality was met, Cox proportional hazards regression were used to assess the impact of PWV ratio on mortality, adjusted for demographic, clinical, biological and pharmacological parameters. In order to compare PWV ratio to other hemodynamic parameters, we first performed a ROC curve analysis to obtain the area under the curve (AUC). Pairwise comparisons of AUCs were performed using MedCalc Software (Ostend, Belgium) with the method of DeLong et al. 9 To further assess the comparative risk associated with each hemodynamic parameter, we determined the HR associated with changes of 1 standardized deviation for each hemodynamic parameter. A multivariate forward Cox regression analysis was used to examine whether PWV ratio still remained a significant risk factor in a multivariate model which included other variables based on statistical significance. A two-tailed p-value <0.05 was considered to be statistically significant (IBM   ®   SPSS ® Statistics, version 20.0). .020 Area under ROC curves with 95% of confidence interval (95% CI) cf-PWV: carotid-femoral pulse wave velocity, AIx@75: augmentation index adjusted for heart rate, PP: pulse pressure, P b : backward pressure wave, P f : forward pressure wave, RM: reflection magnitude, RI: reflection index, cr-PWV: carotid-radial pulse wave velocity, MBP: mean blood pressure, SEVR: subendocardial viability ratio, PP amplification: peripheral PP/ central PP.
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Figure S1: Central pulse wave profile. A) The graph shows the first peak of pressure created by incident pulse wave (P1), second peak of pressure augmented by reflected pulse wave (P2), time of reflection wave (Tr), end-systolic pressure (ESP), augmentation pressure (AP), pulse pressure (PP). B) The panel shows the diastolic pressure time index (DPTI) and systolic pressure time index (SPTI), ejection duration (ED) and diastolic duration (DD).
